Subject:
Global Health Newsletter for December 19, 2024
From Name:
Hannah Johnson, George W. Bush Institute
From Email:
info@bushcenter.org
Reply Email:
hjohnson@bushcenter.org
Date and Time:
18/01/2024 12:00 am

 

The Bush Institute Global Health Newsletter
Hello,

In September, President Xi Jinping announced that China will ramp up investment in Africa with a pledge of approximately $1 billion over the course of three years. A study from Gallup shows that approval ratings of U.S. leadership across Africa fell from 60% in 2021 to 56% in 2023 while China recorded its highest level of leadership approval on the continent in over a decade.

Africa is a powerhouse of opportunity. It's expected that one-third of those entering the global workforce will be African by the 2030s. Africa also holds vital strategic importance. The continent is home to 13 of the 25 fastest-growing economies in the world and serves as a crossroads between East and West, making it critical for U.S. national security.

As authoritarian influence grows, the U.S. has an important role to play in Africa. For the past two decades, the U.S. has driven sustainable health and economic development programming through innovative programs like the President’s Emergency Plan for AIDS Relief (PEPFAR). PEPFAR has not only saved 26 million lives and allowed 7.8 million babies to be born HIV free, but it has also emphasized democratic values like accountability, transparency, and data-driven programming – a contrast to the harsh lending structures and concerning human rights records of authoritarian regimes.

As the new administration prepares to take office, it must reprioritize engagement on the continent. That starts with the passage of a five-year reauthorization of PEPFAR to ensure that we finish the job we started and help Africa end HIV/AIDS as a public health threat by 2030.

Sincerely,

Hannah Johnson
Program Manager of Global Policy
George W. Bush Institute

 

Figure of the Month

2.5 million

That's the number of people who are protected against HIV through pre-exposure prophylaxis (PrEP), thanks to PEPFAR's support. PrEP is a medication regimen for people who do not have HIV but are at high risk of acquiring it, and it is typically administered through antiretroviral pills or injections. PrEP initiations have risen by 500% in the past four years, and PEPFAR is responsible for 90% of those initiations.

 

Source: PEPFAR

 

 

Bush Institute Insights

Since its inception in 2003, PEPFAR has dramatically increased life expectancy in many sub-Saharan African countries. However, the fight against HIV/AIDS remains uneven across nations, with progress closely tied to political will, efficient resource allocation, and community engagement.

The latest chapter in the PEPFAR Beyond 2030 series emphasizes four key tenets that have driven success in countries making the most progress against the HIV pandemic:

  1. Clear, quantifiable goals that dictate strategy, both overall and at the individual country level.
  1. Proactive, rigorous management that ensures both quantitative and qualitative data continuously inform decision-making and resource allocation.
  1. Close collaboration with communities most affected by the pandemic, including host governments and their partners shaping programmatic implementation at the country level.
  1. Cooperation among global institutions (such as UNAIDS, the World Health Organization, and the Global Fund), bilateral programs (like PEPFAR), and country governments to ensure policy and funding align to maximize effectiveness.

 

While some nations have shown remarkable progress, others face persistent barriers such as stigmatizing legal frameworks, misaligned priorities, and limited community engagement. These barriers result in preventable deaths and infections, driving up the long-term costs of HIV programming. Chapter 3 of our PEPFAR Beyond 2030 series argues that holding governments accountable, leveraging data to identify gaps, and tailoring policies to marginalized populations are essential for sustaining progress.

 

Ally Updates

Unitaid announced a $22 million investment to widely distribute lenacapavir, a novel PrEP treatment that only requires two yearly shots. Lenacapavir has the potential to transform HIV prevention by providing long-lasting prevention with minimal treatment. Unitaid will focus its initial distribution on South Africa and Brazil and target at-risk populations.

A recent study published in The New England Journal of Medicine found that lenacapavir, which had already been shown to effectively prevent HIV in women, worked nearly as well in trials with men.

 

In the News
  • U.S. Rep. Bobby Scott, a member of the Congressional HIV/AIDS Caucus, was recognized with the Capitol Hill Champion Award from the National Minority AIDS Council (NMAC) for his advocacy on HIV/AIDS: "I will continue my support for funding for the President's Emergency Plan for AIDS Relief (PEPFAR) as well as the Global Fund to Fight AIDS," said Congressman Scott. "We will not rest until we have ended the HIV epidemic."
  • Over the past decade, global HIV mortality rates have declined, largely driven by progress in sub-Saharan Africa and South Asia. However, the situation has deteriorated in regions such as Eastern Europe and Central Asia, where mortality rates increased 9% since 2010, and North Africa and the Middle East, where mortality rates increased 16.9%. The Lancet predicts that the current HIV control and prevention efforts will fall short of achieving 2030 targets.


 

 
Hannah Johnson
PROGRAM MANAGER, GLOBAL POLICY

GEORGE W. BUSH PRESIDENTIAL CENTER

T: (214) 200-4375
E: Hannah.Johnson@bushcenter.org

www.bushcenter.org

 

About the George W. Bush Institute

The George W. Bush Institute is a solution-oriented nonpartisan policy organization focused on ensuring opportunity for all, strengthening democracy, and advancing free societies. Housed within the George W. Bush Presidential Center, the Bush Institute is rooted in compassionate conservative values and committed to creating positive, meaningful, and lasting change at home and abroad. We utilize our unique platform and convening power to advance solutions to national and global issues of the day. Learn more at www.bushcenter.org

 

George W. Bush Presidential Center
2943 SMU Boulevard
Dallas, Texas 75205

Privacy policy | Email Preferences